Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Renibus Pharmaceuticals

By efain on Tue, 05/19/2020 - 11:24
  • Read more about Renibus Pharmaceuticals

Biomarkers for Identification of COVID-19 Infection

  • Read more about Biomarkers for Identification of COVID-19 Infection

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

  • Read more about Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

A Study of a Candidate COVID-19 Vaccine (COV001)

  • Read more about A Study of a Candidate COVID-19 Vaccine (COV001)

Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

  • Read more about Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

  • Read more about Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

  • Read more about ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

  • Read more about Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong

  • Read more about Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong

In-depth Immunological Investigation of COVID-19.

  • Read more about In-depth Immunological Investigation of COVID-19.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Current page 212
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA